Acidic and basic fibroblast growth factors in human breast tissue.
Previously we have reported changes in fibroblast growth factors (FGF) in conditioned medium (CM) derived from rat mammary tumours undergoing remission. We have used a similar approach to assay for the presence of FGFs in human breast tissue and cell lines. The majority of cancer tissues (35/50), benign tissues (8/9) and all cancer adjacent normal tissues (20/20) released heat labile, NR6 transforming activity which coeluted from heparin with acidic FGF (aFGF) at 0.9-1.1 M NaCl and was neutralised by antibodies to aFGF. The conclusion that the majority of breast cancers contain active aFGF was supported by immunoblotting. The CM of a minority (15/50) of cancers and one benign tissue had highly transforming activity for NR6 cells, and was mitogenic for a breast cancer cell line, was heat labile, and strongly heparin binding, eluting at 1.5-2.0 M salt. It was not immunoreactive with antibodies to aFGF, basic FGF (bFGF) or Kaposi's FGF (kFGF) and its activity was reduced by the presence of aFGF, suggesting competition for the same receptor. Very little aFGF was observed in the CM of these tumours, and neither aFGF nor other FGF activity was detected in CM of breast cell lines.
Smith
J
J
CRC Laboratories, Department of Medical Oncology, Charing Cross Hospital, London, U.K.
Yelland
A
A
Baillie
R
R
Coombes
R C
RC
D001940:Breast / Q000737:chemistry; D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology; D002455:Cell Division; D017077:Culture Media, Conditioned / Q000032:analysis; D005260:Female; D018226:Fibroadenoma / Q000737:chemistry; D016220:Fibroblast Growth Factor 1 / Q000032:analysis*; D016222:Fibroblast Growth Factor 2 / Q000032:analysis*; D006801:Humans; D015151:Immunoblotting; D014407:Tumor Cells, Cultured / Q000737:chemistry
D017077:Culture Media, Conditioned; D016222:Fibroblast Growth Factor 2; D016220:Fibroblast Growth Factor 1